NEW YORK (GenomeWeb News) — PerkinElmer today said first-quarter 2007 revenues increased 14 percent as R&D spending rose 22 percent and profit fell 38 percent.
 
Total receipts for the three months ended April 1 increased to $403 million from $355.5 million year over year, PerkinElmer said. 
 
Revenue for the company’s Life and Analytical Sciences business was up 14 percent to $299.5 million and Optoelectronics revenue was up 11 percent to $103.4 million year over year.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.